Table 1 Baseline characteristics of the 13 included patients.
ID | Age | Sex | BMI | Bsl sCr [mg/dl] | Underlying renal disease | Comorbidities |
|---|---|---|---|---|---|---|
1 | 70 | f | 23.88 | 2.8–3.5 | Recurrent pyelonephritis | DM II, aortic sclerosis |
2 | 50 | m | 24.73 | 2.1–2.8 | Refluxnephropathy | HTN, CABG, St.p. Hepatitis C |
3 | 62 | f | 23.72 | 2–2.5 | Chronic Interstitial nephritis | HIV, St.p. Hepatitis B + E, St.p. thyroid cancer |
4 | 77 | m | 27.78 | 2–2.5 | Cystic kidney disease | Diverticulosis, sigma adenoma |
5 | 22 | m | 26.59 | 2–2.5 | Congenital hydronephrosis | HTN, neurogenic bladder |
6 | 58 | f | 13.98 | 1.3–3.0 | Unknown | Anorexia, chronic pancreatitis, PTX + AutoTX |
7 | 56 | m | 23.88 | 3.2–3.5 | ADPKD | HTN, liver cysts |
8 | 73 | f | 38.67 | 2.5–3 | Goodpasture Syndrom | HTN, St.p. PE, adipositas, cholecystolithiasis |
9 | 24 | f | 25.22 | 2.5–3 | atypical HUS | HTN, St.p. CPR |
10 | 69 | f | 21.88 | 0.8–1.2 | ADPKD | HTN, Sigma diverticulosis |
11 | 61 | m | 21.18 | 2.4–3 | ADPKD | COPD, cerebellum stroke |
12 | 66 | m | 31.02 | 3–4.0 | hepatorenal syndrome | HTN, DM II, LTX, AFIB, adipositas |
13 | 64 | m | 24.86 | 3–3.5 | FSGS | HTN, DVT, adeno carcinoma of abdomen |
